TITLE

Fair Access to Stem Cells

AUTHOR(S)
Holland, Suzanne
PUB. DATE
November 2003
SOURCE
Hastings Center Report;Nov/Dec2003, Vol. 33 Issue 6, p3
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Comments on the article "Public Stem Cell Banks: Considerations of Justice in Stem Cell Research," which addressed the issue of social justice in stem cell line access. Strategies for arriving at just access to stem cell therapies; Limitation of the organ donation system; Appeal of feminist bioethics.
ACCESSION #
11968147

 

Related Articles

  • Plerixafor 'just in time' for stem cell mobilization in a normal donor. Schriber, J.; Fauble, V.; Sproat, L. O.; Briggs, A. // Bone Marrow Transplantation;Jul2011, Vol. 46 Issue 7, p1026 

    A letter to the editor is presented regarding the use of plerixafor in the mobilization of stem cells for transplantation using the so-called just in time rescue strategy on a 56-year-old normal donor.

  • Plasma stromal cell-derived factor-1 during granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilization. Kozuka, T; Ishimaru, F; Fujii, K; Masuda, K; Kaneda, K; Imai, T; Fujii, N; Ishikura, H; Hongo, S; Watanabe, T; Shinagawa, K; Ikeda, K; Niiya, K; Harada, M; Tanimoto, M // Bone Marrow Transplantation;Apr2003, Vol. 31 Issue 8, p651 

    Summary:In this report, we examined plasma stromal cell-derived factor-1 levels in normal healthy donors for allogeneic peripheral blood stem cell transplantation (PBSCT) and in patients for autologous PBSCT using an enzyme-linked immunosorbent assay. The average level of plasma stromal...

  • Five things to know about . . . Donation and transplantation of allogeneic hematopoietic stem cells. Kopolovic, Ilana; Turner, Robert // CMAJ: Canadian Medical Association Journal;11/22/2011, Vol. 183 Issue 17, p2014 

    The article presents five things to know regarding allogeneic hematopoietic stem cells donation and transplantation in Canada. It states that only 30% of Canadian patients with indications for an allogeneic stem cell transplant have a matched related donor, while 70% seek an unrelated donor on...

  • Hematopoietic stem cell donor registry strategies for assigning search determinants and matching relationships. Hurley, C. K.; Setterholm, M.; Lau, M.; Pollack, M. S.; Noreen, H.; Howard, A.; Fernandez-Vina, M.; Kukuruga, D.; Müller, C. R.; Venance, M.; Wade, J. A.; Oudshoorn, M.; Raffoux, C.; Enczmann, J.; Wernet, P.; Maiers, M. // Bone Marrow Transplantation;Feb2004, Vol. 33 Issue 4, p443 

    Summary:Registries and cord blood banks around the world collect and store the HLA types of volunteers in order to identify matched unrelated donors for patients requiring hematopoietic stem cell transplantation. This task is complicated by the many formats in which HLA types are provided by the...

  • European kidney market. Dorozynski, Alexander // BMJ: British Medical Journal (International Edition);11/11/89, Vol. 299 Issue 6709, p1182 

    Reports the scandal involving a kidney donor in France. Formulation of a project on bioethics; Characterization of the purchase of organs as criminal; Adoption of a charter to defend ethical principles of voluntary and anonymous organ donation.

  • Sharing Our Body and blood: Organ Donation and Feminist Critiques of Sacrifice. Mongoven, Ann // Journal of Medicine & Philosophy;Feb2003, Vol. 28 Issue 1, p89 

    Feminist analysis of cultural mythology surrounding organ donation of offers a critical perspective on current U.S. transplant policy. My argument is three-pronged. First, I argue that organ donation is appropriately understood as a sacrifice. Structurally, donation accords both to general and...

  • Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia: In reply. Zander, R. Axel; Bacher, Ulrike; Finke, Jürgen // Deutsches Aerzteblatt International;2/6/2009, Vol. 106 Issue 6, p1 

    The authors argue on the study on the transplantation of allogeneic stem cell in acute myeloid leukemia (AML). They say that such study did not prove the relevance of transplantation of HLA identical unrelated donors to sibling donor transplantation. The comparison of dose reduced conditioning...

  • Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia: Statement Was Not Sufficiently Supported. Herrmann-Frank, Annegret; Koch, Klaus; Lange, Stefan; Sawicki, Peter T. // Deutsches Aerzteblatt International;2/6/2009, Vol. 106 Issue 6, p1 

    The authors probe the article on allogeneic stem cell transplantation in acute myeloid leukemia (AML) by R. Zander and colleagues. The authors said that the publication being cited failed to mention any comparison of related and unrelated donors. They stress the possibility of stem cell...

  • Family donor care management: principles and recommendations. van Walraven, S. M.; Nicoloso-de Faveri, G.; Axdorph-Nygell, U. A. I.; Douglas, K. W.; Jones, D. A.; Lee, S. J.; Pulsipher, M.; Ritchie, L.; Halter, J.; Shaw, B. E. // Bone Marrow Transplantation;Aug2010, Vol. 45 Issue 8, p1269 

    The World Marrow Donor Association (WMDA) is an international organization fostering collaboration in clinical transplantation and promoting the interests of unrelated stem cell donors. The WMDA has developed standards for the recruitment, counseling, work-up and subsequent donations to protect...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics